Report Detail
COVID-19 Impact on Global Cellular Therapy (CT) Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
- RnM4095896 |
- 13 July, 2020 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Cellular therapy (CT) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
Market Analysis and Insights: Global Cellular Therapy (CT) Market
The research report studies the Cellular Therapy (CT) market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Cellular Therapy (CT) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Cellular Therapy (CT) Scope and Segment
The global Cellular Therapy (CT) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cellular Therapy (CT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Stem Cell
Non-Stem Cell
by Application, this report covers the following segments
Hospitals
Clinics
Others
Global Cellular Therapy (CT) market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Cellular Therapy (CT) key players in this market include:
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
1 Market Overview of Cellular Therapy (CT)
- 1.1 Cellular Therapy (CT) Market Overview
- 1.1.1 Cellular Therapy (CT) Product Scope
- 1.1.2 Market Status and Outlook
- 1.2 Global Cellular Therapy (CT) Market Size Overview by Region 2015 VS 2020 VS 2026
- 1.3 Global Cellular Therapy (CT) Market Size by Region (2015-2026)
- 1.4 Global Cellular Therapy (CT) Historic Market Size by Region (2015-2020)
- 1.5 Global Cellular Therapy (CT) Market Size Forecast by Region (2021-2026)
- 1.6 Key Regions, Cellular Therapy (CT) Market Size YoY Growth (2015-2026)
- 1.6.1 North America Cellular Therapy (CT) Market Size YoY Growth (2015-2026)
- 1.6.2 Europe Cellular Therapy (CT) Market Size YoY Growth (2015-2026)
- 1.6.3 Asia-Pacific Cellular Therapy (CT) Market Size YoY Growth (2015-2026)
- 1.6.4 Latin America Cellular Therapy (CT) Market Size YoY Growth (2015-2026)
- 1.6.5 Middle East & Africa Cellular Therapy (CT) Market Size YoY Growth (2015-2026)
2 Cellular Therapy (CT) Market Overview by Type
- 2.1 Global Cellular Therapy (CT) Market Size by Type: 2015 VS 2020 VS 2026
- 2.2 Global Cellular Therapy (CT) Historic Market Size by Type (2015-2020)
- 2.3 Global Cellular Therapy (CT) Forecasted Market Size by Type (2021-2026)
- 2.4 Stem Cell
- 2.5 Non-Stem Cell
3 Cellular Therapy (CT) Market Overview by Application
- 3.1 Global Cellular Therapy (CT) Market Size by Application: 2015 VS 2020 VS 2026
- 3.2 Global Cellular Therapy (CT) Historic Market Size by Application (2015-2020)
- 3.3 Global Cellular Therapy (CT) Forecasted Market Size by Application (2021-2026)
- 3.4 Hospitals
- 3.5 Clinics
- 3.6 Others
4 Global Cellular Therapy (CT) Competition Analysis by Players
- 4.1 Global Cellular Therapy (CT) Market Size (Million US$) by Players (2015-2020)
- 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cellular Therapy (CT) as of 2019)
- 4.3 Date of Key Manufacturers Enter into Cellular Therapy (CT) Market
- 4.4 Global Top Players Cellular Therapy (CT) Headquarters and Area Served
- 4.5 Key Players Cellular Therapy (CT) Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 Cellular Therapy (CT) Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 Gilead Sciences
- 5.1.1 Gilead Sciences Profile
- 5.1.2 Gilead Sciences Main Business
- 5.1.3 Gilead Sciences Products, Services and Solutions
- 5.1.4 Gilead Sciences Revenue (US$ Million) & (2015-2020)
- 5.1.5 Gilead Sciences Recent Developments
- 5.2 Novartis
- 5.2.1 Novartis Profile
- 5.2.2 Novartis Main Business and Company’s Total Revenue
- 5.2.3 Novartis Products, Services and Solutions
- 5.2.4 Novartis Revenue (US$ Million) (2015-2020)
- 5.2.5 Novartis Recent Development and Reaction to Covid-19
- 5.3 Osiris
- 5.5.1 Osiris Profile
- 5.3.2 Osiris Main Business
- 5.3.3 Osiris Products, Services and Solutions
- 5.3.4 Osiris Revenue (US$ Million) & (2015-2020)
- 5.3.5 Vericel Corporation Recent Developments
- 5.4 Vericel Corporation
- 5.4.1 Vericel Corporation Profile
- 5.4.2 Vericel Corporation Main Business
- 5.4.3 Vericel Corporation Products, Services and Solutions
- 5.4.4 Vericel Corporation Revenue (US$ Million) & (2015-2020)
- 5.4.5 Vericel Corporation Recent Developments
- 5.5 Vcanbio
- 5.5.1 Vcanbio Profile
- 5.5.2 Vcanbio Main Business
- 5.5.3 Vcanbio Products, Services and Solutions
- 5.5.4 Vcanbio Revenue (US$ Million) & (2015-2020)
- 5.5.5 Vcanbio Recent Developments
- 5.6 Fujifilm Cellular Dynamics
- 5.6.1 Fujifilm Cellular Dynamics Profile
- 5.6.2 Fujifilm Cellular Dynamics Main Business
- 5.6.3 Fujifilm Cellular Dynamics Products, Services and Solutions
- 5.6.4 Fujifilm Cellular Dynamics Revenue (US$ Million) & (2015-2020)
- 5.6.5 Fujifilm Cellular Dynamics Recent Developments
- 5.7 JCR Pharmaceuticals
- 5.7.1 JCR Pharmaceuticals Profile
- 5.7.2 JCR Pharmaceuticals Main Business and Company’s Total Revenue
- 5.7.3 JCR Pharmaceuticals Products, Services and Solutions
- 5.7.4 JCR Pharmaceuticals Revenue (US$ Million) (2015-2020)
- 5.7.5 JCR Pharmaceuticals Recent Development and Reaction to Covid-19
- 5.8 Beike Biotechnology
- 5.8.1 Beike Biotechnology Profile
- 5.8.2 Beike Biotechnology Main Business
- 5.8.3 Beike Biotechnology Products, Services and Solutions
- 5.8.4 Beike Biotechnology Revenue (US$ Million) & (2015-2020)
- 5.8.5 Beike Biotechnology Recent Developments
- 5.9 Golden Meditech
- 5.9.1 Golden Meditech Profile
- 5.9.2 Golden Meditech Main Business
- 5.9.3 Golden Meditech Products, Services and Solutions
- 5.9.4 Golden Meditech Revenue (US$ Million) & (2015-2020)
- 5.9.5 Golden Meditech Recent Developments
- 5.10 Guanhao Biotech
- 5.10.1 Guanhao Biotech Profile
- 5.10.2 Guanhao Biotech Main Business
- 5.10.3 Guanhao Biotech Products, Services and Solutions
- 5.10.4 Guanhao Biotech Revenue (US$ Million) & (2015-2020)
- 5.10.5 Guanhao Biotech Recent Developments
6 North America
- 6.1 North America Cellular Therapy (CT) Market Size by Country
- 6.2 United States
- 6.3 Canada
7 Europe
- 7.1 Europe Cellular Therapy (CT) Market Size by Country
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
- 7.7 Nordic
- 7.8 Rest of Europe
8 Asia-Pacific
- 8.1 Asia-Pacific Cellular Therapy (CT) Market Size by Region
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest of Asia-Pacific
9 Latin America
- 9.1 Latin America Cellular Therapy (CT) Market Size by Country
- 9.2 Mexico
- 9.3 Brazil
- 9.4 Rest of Latin America
10 Middle East & Africa
- 10.1 Middle East & Africa Cellular Therapy (CT) Market Size by Country
- 10.2 Turkey
- 10.3 Saudi Arabia
- 10.4 UAE
- 10.5 Rest of Middle East & Africa
11 Cellular Therapy (CT) Market Dynamics
- 11.1 Industry Trends
- 11.2 Market Drivers
- 11.3 Market Challenges
- 11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Cellular Therapy (CT). Industry analysis & Market Report on COVID-19 Impact on Global Cellular Therapy (CT) is a syndicated market report, published as COVID-19 Impact on Global Cellular Therapy (CT) Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Cellular Therapy (CT) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
